Advanced in Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)

Dr. Joel A. Block

Rheumatology
Rush University Medical Group
1620 W Harrison St, 
Chicago, IL 
Accepting New Patients
Offers Telehealth
43 Years of Experience
Advanced in Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)
Rush University Medical Group
1620 W Harrison St, 
Chicago, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Joel Block is a Rheumatologist in Chicago, Illinois. Dr. Block has been practicing medicine for over 43 years and is rated as an Advanced provider by MediFind in the treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome). His top areas of expertise are Fibromyalgia, Arthritis, Rheumatoid Arthritis (RA), and Systemic Lupus Erythematosus (SLE). Dr. Block is currently accepting new patients.

His clinical research consists of co-authoring 109 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome).

Graduate Year
1982
Specialties
Rheumatology
Licenses
Internal Medicine in IL
Hospital Affiliations
Rush University Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Zing Health
  • MEDICARE MAPD
  • MEDICARE SNP
View 8 Less Insurance Carriers -

Locations

RUSH UNIVERSITY MEDICAL GROUP
1620 W Harrison St, Chicago, IL 60612
Other Locations
RUSH UNIVERSITY MEDICAL GROUP
1700 W Van Buren St, Chicago, IL 60612

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: October 12, 2023
Intervention Type: Drug
Study Drugs: Olokizumab, Methotrexate
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

109 Total Publications

RheuMetric Physician 0 to 10 Estimates of Inflammation, Damage, and Patient Distress at Initial Versus Follow-Up Visits in Contemporary Rheumatology Care.
RheuMetric Physician 0 to 10 Estimates of Inflammation, Damage, and Patient Distress at Initial Versus Follow-Up Visits in Contemporary Rheumatology Care.
Journal: ACR open rheumatology
Published: May 31, 2024
Similar Doctors
Distinguished in Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)
Dr. Anisha B. Dua
Rheumatology
Distinguished in Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)
Dr. Anisha B. Dua
Rheumatology
675 N St Clair St Ste 14-100, Galter Pavilion, 
Chicago, IL 
 (3.2 miles away)
312-695-8628
Experience:
18+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Anisha Dua is a Rheumatologist in Chicago, Illinois. Dr. Dua has been practicing medicine for over 18 years and is rated as a Distinguished provider by MediFind in the treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome). Her top areas of expertise are Giant Cell Arteritis (GCA), Temporal Arteritis, Granulomatosis with Polyangiitis, Vasculitis, and Tissue Biopsy.

Advanced in Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)
Dr. Zineb Aouhab
Rheumatology
Advanced in Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)
Dr. Zineb Aouhab
Rheumatology

Loyola University Medical Center

2160 S 1st Ave, 
Maywood, IL 
 (8.7 miles away)
708-216-9000
Languages Spoken:
English, Arabic, French
See accepted insurances
Accepting New Patients

Zineb Aouhab is a Rheumatologist in Maywood, Illinois. Dr. Aouhab is rated as an Advanced provider by MediFind in the treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome). Her top areas of expertise are Giant Cell Arteritis (GCA), Juvenile Temporal Arteritis, Rheumatoid Arthritis (RA), and Interstitial Keratitis. Dr. Aouhab is currently accepting new patients.

Advanced in Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)
Dr. Amy M. Archer
Rheumatology
Advanced in Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)
Dr. Amy M. Archer
Rheumatology
675 N Saint Clair St, Suite 14-100 (div Of Rheumatology), 
Chicago, IL 
 (2.8 miles away)
312-695-8628
Languages Spoken:
English
See accepted insurances

Amy Archer is a Rheumatologist in Chicago, Illinois. Dr. Archer is rated as an Advanced provider by MediFind in the treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome). Her top areas of expertise are Necrotizing Vasculitis, Granulomatosis with Polyangiitis, Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome), and Giant Cell Arteritis (GCA).

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Block's expertise for a condition
ConditionClose
    View All 25 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile